$AMMJ Announces $175,000 Satchel(TM) Order from Kush Bottles(TM) Colorado

American Cannabis Company continues to add to its strong market presence as a provider of industry solutions to businesses operating in the regulated cannabis sector. The Company attributes its success to its close relationship with clients, deep understanding of the industry’s needs, and the ability to not only allow dispensaries to provide packaging that is compliant with state laws, but one that also allows dispensaries to provide customers with a high-quality branded packaging product.

Corey Hollister, president and CEO, American Cannabis Company, commented: “We’ve had success with the adoption of the Satchel(TM) in the marketplace, even with the change in the state exit packaging regulations. Our clients view our packaging product as a marketing tool as well as a compliance mechanism to ensure medical cannabis is not getting into the hands of children, and this is consistent with our vision for the product. This is a significant order from our distributor and further evidences our ability to continue to be able to provide compelling value driven solutions to our clients.”

About American Cannabis Company, Inc.:

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and American Cultivator Company, a group purchasing organization, we support our clients from concept to creation to commercialization to on-going operations.

For more information, please visit: www.americancannabiscompanyinc.com.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visitwww.sec.gov.

Contact:

Trent Woloveck
Chief Operating Officer
trent@americancannabisconsulting.com
(303) 974-4770